Implant Sciences Corporation (AMEX: IMX) develops, manufactures and markets highly sensitive trace explosive detection devices to be used at security checkpoints and other locations around the world. The Company also provides valuable ion implantation services for a growing range of customers in the semiconductor industry. Lastly, we serve parts of the medical community by modifying the surface characteristics and applying sophisticated coatings to orthopedic joint implants and other medical products which provides benefits such as reduced wear and increased biocompatibility, thereby increasing the value of the implants.

Highlights

Proprietary patented technology with opportunity in multiple business segments. Implant Sciences' methods of ion implantation allow the Company to exploit numerous commercial opportunities, such as trace explosives detection, high technology ion based semiconductor applications, and the coating of several medical items such as artificial joints, stents, and dental implants.

Rich pipeline of products to fuel future growth in all business segments. The Company's expertise in explosives detection systems is expected to continue to grow as world events continue to demonstrate the need for improve security in locations such as airports, harbors, government buildings, mass transit points, and similar locations. As governments and other security oriented elements of the market continue to fund and implement new security programs, new opportunities will be presented to the Company.

Seasoned management team. Anthony Armini, Ph.D., Chief Executive Officer, is a physicist with 31 years of industry experience, founded the company in 1984. Phillip C. Thomas, COO, is an experienced executive with over 25 years of experience building growth companies. Diane Ryan, Chief Financial Officer, has over 20 years of financial experience, while Stephen Bunker, Ph.D., vice President, Chief Scientist and co-founder, has 29 years of high technology experience in a variety of related industries.

History of sales growth and solid financial position. Along with steady sales growth, as of June 30th 2007, the Company had approximately $10,000,000 in cash and marketable securities on hand with minimal debt.